As Lentiviral vectors have transformed medicine with their safety and efficacy, they have created a demand for products that far exceed current capacity. Traditional manufacturing systems have seen long wait times and critical raw material shortages cause delays in the development and deployment of these life-altering therapies. Our Intelligent Vector Solutions(TM) can be used to manufacture ANY LENTI, ANY SCALE(TM) to provide our clients an END TO END solution, speeding their development, and securing their supply chain. iVexSol, where technology meets capacity.
Total Funding: $15,300,000
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2019
Cell Biology Expert
Worcester, Massachusetts
Lentiviral Vector Downstream Processing Expert
Worcester, Massachusetts
Molecular Biology Expert
Worcester, Massachusetts
